Leading experts in health, law and emerging technologies join Stem Cells Australia

23 July 2018
Members of HeLEX@Melbourne are collaborating with Stem Cells Australia
Digital health records, genome sequencing and biobanks are at the vanguard of medical advancement, allowing researchers to solve health problems through technology in previously unimaginable ways.

But the increasing use of data from this technology, and the sheer volume of it that needs to be managed by researchers and organisations, throws up a raft of challenging legislative and ethical questions for health practitioners.

The HeLEX@Melbourne team at Melbourne Law School are a new research program created to address these legislative and ethical questions. They provide academic advice on law and best practice around the sharing and management of data generated from the use of digital technologies.

Professor Jane Kaye, Director of the Centre for Health, Law and Emerging Technologies (HeLEX) at the University of Oxford, established the program last year. Dr Jessica Bell and Dr Harriet Teare are the first visiting scholars from Oxford who are helping to establish the Melbourne arm of the research group. They have been joined by Dr Megan Prictor, Dr Carolyn Johnston and Associate Professor Mark Taylor, from the University of Melbourne. 

Members of the HeLEX@Melbourne team, Professor Jane Kaye and Dr Jessica Bell have joined have Stem Cells Australia initiative as Associate Investigators and will work closely with A/Professor Megan Munsie and Dr Claire Tanner

Together, they aim to identify and address potential ethical, regulatory and societal barriers to advancing stem cell research and its clinical application. Jane and Jessica’s expertise in regulation and governance, at both a domestic and international perspective, greatly compliments and enhances the activities of Stem Cells Australia’s  Engagement, Ethics and Policy Program

Original article: "Keeping Pace with the Health Revolution